Clinical Significance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma

Table 3

Multivariate analysis of BRCA1 methylation status and clinical features.

Clinical features	BRCA1 Methylation
	P	OR	95%CI
Age	.11	0.17	0.02–1.5
TNM	.218	0.173	0.01–2.81
Clinical stage	.022	53.8	1.7–1640
Metastasis	.891	0.8	0.03–16.6
Tumor size	.037	0.05	0.004–0.84
5-y survival	.017	20.7	1.7–251.5